Stay updated on Tabelecleucel for EBV+ PTLD Clinical Trial
Sign up to get notified when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.

Latest updates to the Tabelecleucel for EBV+ PTLD Clinical Trial page
- Check6 days agoChange DetectedRevision label on the page changed from v3.6.2 to v3.6.3, indicating a new page revision. This is a minor metadata update that does not alter the study content or data.SummaryDifference0.0%

- Check13 days agoChange DetectedThe revision label was updated from v3.6.0 to v3.6.2, indicating a new release of the page's versioning metadata. This change does not affect the visible content or user-facing features.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded new quick-access sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, and the page revision tag updated to v3.6.0.SummaryDifference0.2%

- Check35 days agoChange DetectedA new page revision, v3.5.5, has been added to replace the previous v3.5.4, indicating a routine update to the page's revision history rather than substantive changes to the trial details.SummaryDifference0.0%

- Check49 days agoChange DetectedUpdates add new study contacts and their details (Pere Barba, MD; Federica Cattaneo; Glen Lew as Study Director) and remove older contact Claire Fabre, while indicating site recruitment progression with 'Completed' statuses across locations.SummaryDifference0.7%

- Check56 days agoChange DetectedThe study record's revision label was updated from v3.5.3 to v3.5.4, indicating a newer version of the document.SummaryDifference0.0%

Stay in the know with updates to Tabelecleucel for EBV+ PTLD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tabelecleucel for EBV+ PTLD Clinical Trial page.